Famotidine

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• FDA Drug Label and OTC Monograph: Famotidine (Pepcid/Pepcid AC) — H2 receptor antagonist; renal elimination; no NDMA formation; ranitidine alternative; pediatric approved age 1+; 0.5 mg/kg/day dosing; COVID clinical trial no benefit; Pregnancy Category B REGULATORY · 2020
• American Association of Poison Control Centers (AAPCC): National Poison Data System Annual Report — Pediatric cocaine/stimulant exposures; body packing emergencies; levamisole agranulocytosis; accidental child ingestion outcomes (2022) REGULATORY · 2022
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• EPA CompTox CTX API: predicted properties for DTXSID5023039 (Famotidine) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.